4//SEC Filing
Murphy Nicole 4
Accession 0001127602-24-012405
CIK 0000875045other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 8:11 PM ET
Size
8.5 KB
Accession
0001127602-24-012405
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
Murphy Nicole
Head of Pharm Ops and Tech
Transactions
- Exercise/Conversion
Common Stock
2024-04-01+240→ 9,751.374 total - Exercise/Conversion
Restricted Stock Unit
2024-04-01−240→ 0 totalExercise: $0.00Exp: 2024-04-01→ Common Stock (240 underlying) - Tax Payment
Common Stock
2024-04-01$214.83/sh−117$25,135→ 9,634.374 total
Footnotes (2)
- [F1]1. Includes 93.3846 shares acquired under the Biogen Inc. employee stock purchase plan on 3/28/2024.
- [F2]This award was granted to the reporting person on April 1, 2021. The final portion of the awards vested on the third anniversary of the grant date.
Documents
Issuer
BIOGEN INC.
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001910644
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 8:11 PM ET
- Size
- 8.5 KB